Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients
Eye, 06/04/2012
Nguyen QD et al. – A single intravitreal injection of PF–0523655 ≤3000μg seems safe and well tolerated in eyes with neovascular age–related macular degeneration.



